Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 21,319 shares at $187.41 ($4.0M) on 2015-12-11, disclosed to the SEC on 2015-12-15.
Seasonal sale ($4.0M) by Director — this insider has traded ALXN in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $187.41 | 16,967 | $3.2M | 79.5% |
| 2 | $188.13 | 4,352 | $819K | 20.5% |
| Total | $187.56 avg | 21,319 | $4.0M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |